Urology Care Foundation

Somatic and Germline Genetic Testing for Advanced Prostate Cancer

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...
Becker's Hospital Review

The scope of the ‘cancer’ label debate

In the last year, several cancers have been the subject of debate regarding whether the label of “cancer” should be applied to them. In 2024, low-risk prostate cancer entered the spotlight as a ...
Seeking Alpha

Bayer to seek label expansion for prostate cancer drug after late-stage trial win

Bayer (OTCPK:BAYZF) on Wednesday announced plans to seek an expanded label for its prostate cancer therapy Nubeqa (darolutamide) after the oral androgen receptor inhibitor (ARi) as part of combination ...
ascopubs.org

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant The phase II KEYNOTE-199 study included three cohorts of patients with mCRPC treated with ...
ascopubs.org

An open-label phase 1, window-of-opportunity study of ultrasound-guided long acting periprostatic neuraxial block with ethanol in patients with high-risk prostate cancer.

Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis. This is an ASCO ...
Cure Today

Not All Prostate Cancer Follows a Slow-Growing Course

GG1 prostate cancer can have heterogeneous outcomes, with some patients having intermediate- or high-risk disease, challenging the notion of GG1 as uniformly low-risk. Removing the cancer label for ...